“SolveBio announced today it has been awarded $1,497,112 by the National Institute of General Medical Sciences (NIGMS) for the project titled: “The Variant Explorer: a cloud-based data integration and visualization system for improving clinical interpretation of sequenced genetic variants”. The presence or absence of specific genetic variants is increasingly important and significant in medical care…”
“The grant will fund SolveBio’s development of technologies for the exploration, evaluation, and utilization of genetic variant data in BioPharma R&D. SolveBio’s technology is critical to adapting to the new paradigm of drug development that integrates real-world evidence, outcomes data, and NGS data from patients to better understand biomarkers correlated with drug resistance…”
Source: SolveBio Awarded $1.5 Million from the National Institutes of Health to Expand Genomic Applications in Precision Medicine. January 5, 2018. TMC News. Read the full release here.
